Bausch Health Companies Inc

Research Bausch Health Companies Inc (BHC) on Bullrun: market cap USD 1.81B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBHC
• ExchangeNYSE
• CountryCanada
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 1.81B
• Financial periodFY2025
• RevenueUSD 10.27B
• Revenue growth6.7%
• Net incomeUSD 157.00M
• Free cash flowUSD 1.00B

Valuation Snapshot

latest market cap is USD 1.81B.

About Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health.

Frequently asked questions

What is Bausch Health Companies Inc's market cap?

Bausch Health Companies Inc's market capitalization is USD 1.81B.

What does Bausch Health Companies Inc do?

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.